fda glp-1 news november 2025 Compounded" drugs | Health Communication Research Laboratory FDA Accepts NDA Submission for

Scientist-formulated, non-GMO, and made for consistent, everyday supplementation

In turn, those SCFAs signal cells in the gut to release GLP-1 into the bloodstream

Patients with no history of uveitis have a far reduced risk of developing the eye inflammation when taking GLP-1 drugs to treat diabetes or obesity.

Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.

Can semaglutide cause allodynia or nerve pain

There is a particular type of GLP-1 telehealth provider that gets overlooked in most comparison articles: the one that actually